Gapping up In reaction to strong earnings/guidance: EDAP+23.7%, BBY +9.3%, WSM +7.5%, CRMT +7%, ATTO +5.9%, GFI +5.4%, MBLY +4.3%, MIK+3.4%, GLOG +3.2%, DLTR +3.1%, KLAC +0.5%, (also declares special cash dividend, announces planned redemption of Senior Notes due 2018, outlook for Q2)
Select metals/mining stocks trading higher: HMY+2.4%, AUY +1.8%, AUY +1.8%, KGC +1.5%, ABX+1.5%, AEM +1.3%, GDX +1.1%
Other news: CZR +15.6% (co disclosed that in a previously proposal it considered restructuring Caesars Entertainment Operating Company as a REIT), EYES +10.2% (cont strength post IPO),NAVB +5.7% (announced that the European Commission has granted marketing authorization for Lymphoseek 250 micrograms kit for radiopharmaceutical preparation), MAS +4.7% (still checking), CLD +4.5% (announced termination of $100 mln public offering of mandatory convertible preferred stock), HGG +3.4% (in symp with BBY earnings), RDCM +3.1% (received a $4.3 mln purchase order from an existing Tier-1 customer in the APAC region), DG +2.6% (in symp with DLTR earnings), SPEX +2.5% (SPEX litigation against CSCO continues on patents acquired from Rockstar Consortium), YGE +1.8% (still checking), GRPN+1.7% (Director disclosed purchase of 30000 shares, worth total of $232.6K ), ATVI +1.1% (announced that an agreement has been reached to settle the consolidated derivative and class action shareholder case; multiple insurance companies to pay ATVI $275 mln), PPS +1.1% (announced a new $200 mln stock and note repurchase program)
Analyst comments: TRUE +2.4% (upgraded to Outperform at RBC Capital Mkts), JBLU +1.9% (upgraded to Neutral from Underperform at Credit Suisse), YUM +0.8% (upgraded to Buy from Neutral at Janney), SYT +0.7% (upgraded to Buy at Kepler)